HCFA Medicare Clinical Trials Coverage Criteria Near Completion
This article was originally published in The Gray Sheet
Executive Summary
HCFA expects to issue self-certification criteria within the next month for clinical trials seeking Medicare coverage of routine care costs, HCFA Division of Items & Devices Director John Whyte, MD, announced at a Feb. 6 FDLI-sponsored conference held in Washington, D.C.
You may also be interested in...
IRB Approval Seen As Minimum Bar For Medicare Clinical Trial Coverage
An multi-agency panel convened by the Agency for Healthcare Research and Quality is considering whether IRB approval alone is sufficient proof that a clinical trial merits Medicare coverage.
HCFA Rolls Out "Generous" Clinical Trials Coverage Policy
HCFA's decision to provide coverage for clinical trial routine care costs will not affect its current policy allowing coverage for category B device trials, the agency clarifies in a Sept. 19 notice.
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.